Palmer Luckey Made a Genetically Modified Military Dog Startup

Genetically enhanced military dogs are now a funded reality, with the first expected in 2027.

Palmer Luckey, co-founder of Anduril, and Ben Lamm, co-founder of Colossal Biosciences, have launched a new startup called Warhound. The company aims to create genetically enhanced dogs for U.S. military, law enforcement, and emergency services. Warhound has secured $200 million in funding to establish a domestic supply of elite working dogs and reduce reliance on European breeders. The startup plans to gene-edit and clone top-performing military and police dogs, focusing initially on breeds like Belgian Malinois, labs, and German Shepherds. The first gene-editing efforts will address common health issues such as hip dysplasia, with future plans to enhance olfactory receptor genes from wolves. Warhound also intends to equip its dogs with advanced equipment, software, and situational awareness tools from Anduril. The first litters are anticipated in early 2027, with David Spirk, former DoD chief data officer, serving as CEO. Investors include In-Q-Tel, Sequoia Capital, and ARK Invest, and Colossal Biosciences holds an ownership stake.

The launch of Warhound signifies a significant push towards leveraging advanced biotechnology and AI for canine enhancement in security and defense sectors. This move addresses a critical bottleneck in acquiring specialized working dogs, potentially altering defense procurement and training paradigms. The integration of Anduril's cybernetics with gene-edited canines hints at a future where animal-machine integration becomes a tangible asset on the battlefield and in law enforcement.

Warhound's ambition to develop "elite working dogs" by enhancing genetic traits and integrating advanced technology represents a new frontier in bio-integrated defense systems. The substantial $200 million funding, coupled with high-profile investors, suggests a strong market belief in the efficacy and demand for such specialized animal assets. Future developments will likely focus on the ethical considerations and practical integration of these enhanced canines into existing operational frameworks.